“Prevention of Blindness” Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD.

Slides:



Advertisements
Similar presentations
Medical Retina and Macular Diseases
Advertisements

Falls prevention. As you get older, so do your eyes This can affect your life in many ways.
DIABETES AND THE EYE: WHAT YOU SHOULD KNOW ABOUT IT
BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.
Evan (Jake) Waxman MD PhD
Welcome to CNIB’s InFocus Webinar Series
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
DIABETIC RETINOPATHY.
Rites of Sight Your Second 50 years A Presentation of the American Optometric Association.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Serum Lipids and Proliferative Diabetic Retinopathy Klein BEK, Myers CE, Howard.
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Risk FactorGoal SmokingCessation, using counseling or medications ObesityWeight Reduction by: Exercise: 30 – 60 minutes of moderate intensity aerobic.
F. Kianersi M.D 1387 / 12 / 1.  Diabetes mellitus presently afflicts an estimated 20.2 million Americans, with expectations of over 30 million cases.
Diabetes Mellitus Type 2
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
0 Glaucoma can take your sight away. Keep Vision in Your Future.
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
Diabetic Retinopathy. Diabetic retinopathy is the most common cause of new cases of blindness among adults years of age. Each year, between 12,000.
Basic Considerations for Prevention of Blindness in Diabetes Care and Education Prof. Morsi Arab Emeritus Professor of Medicine University of Alexandria.
The Canadian Association of Optometrists
RENAL DISEASE IN DIABETES
OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.
Prevention of Vision Loss From Diabetes Counseling, persistence, and multiple telephone calls along with low-literacy level educational material impact.
REFERENCES 1.Roberts E, Morgan R, King D, Clerkin L. Funduscopy: a forgotten art? Postgrad Med J. 1999; 75: McComiskie JE, Greer RM, Gole GA.
The Diabetic Retinopathy Clinical Research Network
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Diabetes and Your Eyes.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Diabetes and the Eyes Kenyon Anderson, O.D.. Blindness Risk Diabetic eye disease, caused by diabetes, is a leading cause of blindness and vision loss.
Prospective Telemedicine Screening for Diabetics at High Risk for Retinopathy. PI- Jayne S Weiss, MD LSUHSC-NO.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Low Cost Fundus Camera P15590 Presented by: Daniel Sui, Ian Morency, Kevin Labourdette, Kyle Burden, Quang Huynh, Tommy Casero September 10 th, 2014.
Diabetic Retinopathy.
Focus Area 28 – Vision Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Slides current until 2008 Diabetic retinopathy. Curriculum Module III-7a – Diabetic retinopathy Slide 2 of 39 Slides current until 2008 Diabetic eye disease.
Section 5: Configuration of healthcare to manage CKD.
t IMPLEMENTATION OF A SCREENING PROGRAM FOR THE EARLY DETECTION OF DIABETIC RETINOPATHY USING A NON-MYDRIATIC CAMERA IN PRIMARY CARE Antoni Peris Carlos.
ERECTILE DYSFUNCTION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 4 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 5.
Impatto della terapia ipoglicemizzante sulla retinopatia diabetica Raffaele Napoli Dipartimento di Scienze Mediche Traslazionali Università Federico II.
Josephine Carlos-Raboca, M.D. Makati Medical Center
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 1 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Diabetic Retinopathy Alan D. Letson, MD Professor & William H. Havener Chair in Ophthalmology Department of Ophthalmology Part I:
Women’s Health Evening Portishead Medical Group Monday 12 th October pm.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Philip Anderton BOptom PhD Visiting Optometrist Manilla Health Service HNEAHS.
Ophthalmology in Malawi DR JOSEPH MSOSA.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
6-year vision loss in patients newly diagnosed with clinical type 2 diabetes. What can the patients expect? Niels de Fine Olivarius Volkert Siersma Gitte.
Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.
How Diabetes Steals Vision from Your Patients
I NTEGRATED CARE B ASED ON THE G UIDELINES FOR PATIENTS WITH DIABETIC RETINOPATHY By Yanira I. Marrero McFaline MD.
Glossophobia.
Dr.Ravi kant Associate Professor Medicine ,AIIMS Rishikesh
Diabetic Retinopathy Screening: A Public Health Perspective
Ocular Manifestations of Diabetes
US Medical Professionals’ Knowledge of the Diabetes Control and Complications Trial Austin Bach, DO, MPH, Mohamad ElChurafa, BS, Daniel Solano, DO, Marcos.
Caring Your Vision - Special Aspects
The cumulative incidence of any major eye disease end point (PDR, CSME, application of laser, or development of blindness) is shown in relation to diabetes.
Diabetes: Microvascular Complications and Foot Care
Early Treatment of Diabetic Retinopathy
Presentation transcript:

“Prevention of Blindness”

Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD

Diabetic retinopathy is the leading cause of blindness in industrialized world.

Diabetic retinopathy after 20 years of DM:Diabetic retinopathy after 20 years of DM: Type 1  99% Type 2  60% (WESDR)

After 20 years of DM:After 20 years of DM: Younger onset patients (<30 yrs at diagnosis)  3.6% Legally blind Older onset patients (≥30 yrs at diagnosis)  1.6% Legally blind (WESDR)

Legal blindness attributable to DR: Younger-onset group  86% Older-onset group  33% (WESDR)

Is diabetic retinopathy a preventable disease?

YES

With early detection and timely applied laser treatment we can intervene in the natural course of diabetic retinopathy and prevent % of the vision loss due to diabetes.

HOW?

Through simple yet very important health messages

First Message

“It is mandatory to have a fundus examination of every diabetic patient taken every year with proper referral”

Where?

Screening examination in the office of the GP or the diabetologist where the patient already goes regularly.

Timing of first dilated ophthalmologic examination: First examination Age of onset of diabetes By 5 years after onset Not before puberty 0-30 yrs Once diagnosedOver 30 yrs During first trimesterWhile pregnant Following AAO preferred practice pattern

Recommended follow up schedule: Follow upFindings on first examination Annual None to minimal retinopathy 6-12 m Mild-to-moderate NPDR / no macular edema 4-6 m Mild-to-moderate NPDR / early macular edema 3-4 m Mod-to-severe NPDR Each trimester During pregnancy Consider treatment Very severe NPDR or early PDR Recommend treatment High-risk PDR or CSME Following AAO preferred practice pattern

A fully dilated examination * Sensitivity decreases by 50% if the eyes are undilated. Photography through dilated or (undilated) pupils * Easy – Acceptable – Mobile teams * Offers twice the utilization as a usual referral based system of care. Method of examination:

Second Message

“Prevention of diabetic retinopathy is attainable once the diagnosis of diabetes mellitus is made and intensive treatment instituted”

Diabetes Control and Complication Trial (DCCT) In 9 years, a 76% reduction of diabetic retinopathy progression was found in intensive group compared with the conventional treatment group.

Third Message

“Treat associated hypertension tightly”

United Kingdom Prospective Diabetes Study (UKDPS) After 7.5 years, the group with tight control of hypertension (<105/85 mmHg) showed a 34% reduction in the risk of progression of retinopathy compared to the less tight control group (<180/105 mmHg).

Is it feasible?

Yes it is possible to greatly reduce the incidence of blindness from diabetic retinopathy through: 1.Early detection of DR 2.A tighter control of diabetes 3.A tight control of associated hypertension 4.Patient education and compliance